OnKure Therapeutics, Inc. OKUR Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s total current liabilities?
- OnKure Therapeutics, Inc. (OKUR) reported total current liabilities of $14.33M in Q1 2026.
- How has OnKure Therapeutics, Inc.'s total current liabilities changed year-over-year?
- OnKure Therapeutics, Inc.'s total current liabilities increased by 63.1% year-over-year, from $8.79M to $14.33M.
- What is the long-term trend for OnKure Therapeutics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), OnKure Therapeutics, Inc.'s total current liabilities has grown at a 5.3% compound annual growth rate (CAGR), from $4.58M to $5.92M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.